Evidence map›Paper›PMID 28651603›Full record

ArticleJournal of neuroinflammation2017

A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation.

Srikant Rangaraju, Syed Ali Raza, Andrea Pennati, Qiudong Deng, Eric B Dammer, Duc Duong, Michael W Pennington, Malu G Tansey, James J Lah, Ranjita Betarbet and 2 more

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Functional Potassium Channels in Macrophages.The Journal of membrane biology · 2023
    Review
  11. Frontiers in pharmacology · 2023
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Unique molecular characteristics and microglial origin of Kv1.3 channel-positive brain myeloid cells in Alzheimer's disease.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Srikant RangarajuDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA. srangar@emory.edu.ORCID 0000-0003-2765-1500
Syed Ali RazaDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Andrea PennatiDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53726, USA.
Qiudong DengDepartment of Biochemistry, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Eric B DammerDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Duc DuongDepartment of Biochemistry, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Michael W PenningtonPeptides International, Louisville, KY, 40299, USA.
Malu G TanseyDepartment of Physiology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
James J LahDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Ranjita BetarbetDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Nicholas T SeyfriedDepartment of Biochemistry, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Allan I LeveyDepartment of Neurology, Emory University, 615 Michael Street, Suite 525, Atlanta, GA, 30322, USA.
Emory University · USPeptides International (United States) · USUniversity of Wisconsin–Madison · US

Funding

The Emory Alzheimer's Disease CenterP50AG025688 · NIA · EMORY UNIVERSITY · PI LEVEY, ALLAN I · 2005 to 2019
$25.7M
Discovery of Novel Proteomic Targets in Alzheimer's DiseaseU01AG046161 · NIA · EMORY UNIVERSITY · PI BENNETT, DAVID ALAN, GESCHWIND, DANIEL H · 2014 to 2018
$8.4M
ENNCF - Viral Vector CoreP30NS055077 · NINDS · EMORY UNIVERSITY · PI BASSELL, GARY J · 2008 to 2018
$6.8M
Microglial and macrophage potassium channels as regulators of neuroinflammation in Alzheimer's DiseaseK08NS099474 · NINDS · EMORY UNIVERSITY · PI RANGARAJU, SRIKANT · 2016 to 2020
$943k
NIA NIH HHS P50 AG025688NIA NIH HHS U01 AG046161NINDS NIH HHS K08 NS099474NINDS NIH HHS P30 NS055077
6 · The paper itself

Abstract

backgroundKv1.3 potassium channels regulate microglial functions and are overexpressed in neuroinflammatory diseases. Kv1.3 blockade may selectively inhibit pro-inflammatory microglia in neurological diseases but the molecular and cellular mechanisms regulated by Kv1.3 channels are poorly defined.

methodsWe performed immunoblotting and flow cytometry to confirm Kv1.3 channel upregulation in lipopolysaccharide (LPS)-activated BV2 microglia and in brain mononuclear phagocytes freshly isolated from LPS-treated mice. Quantitative proteomics was performed on BV2 microglia treated with control, LPS, ShK-223 (highly selective Kv1.3 blocker), and LPS+ShK-223. Gene ontology (GO) analyses of Kv1.3-dependent LPS-regulated proteins were performed, and the most representative proteins and GO terms were validated. Effects of Kv1.3-blockade on LPS-activated BV2 microglia were studied in migration, focal adhesion formation, reactive oxygen species production, and phagocytosis assays. In vivo validation of protein changes and predicted molecular pathways were performed in a model of systemic LPS-induced neuroinflammation, employing antigen presentation and T cell proliferation assays. Informed by pathway analyses of proteomic data, additional mechanistic experiments were performed to identify early Kv1.3-dependent signaling and transcriptional events.

resultsLPS-upregulated cell surface Kv1.3 channels in BV2 microglia and in microglia and CNS-infiltrating macrophages isolated from LPS-treated mice. Of 144 proteins differentially regulated by LPS (of 3141 proteins), 21 proteins showed rectification by ShK-223. Enriched cellular processes included MHCI-mediated antigen presentation (TAP1, EHD1), cell motility, and focal adhesion formation. In vitro, ShK-223 decreased LPS-induced focal adhesion formation, reversed LPS-induced inhibition of migration, and inhibited LPS-induced upregulation of EHD1, a protein involved in MHCI trafficking. In vivo, intra-peritoneal ShK-223 inhibited LPS-induced MHCI expression by CD11b

conclusionsWe have unraveled novel molecular and functional roles for Kv1.3 channels in pro-inflammatory microglial activation, including a Kv1.3 channel-regulated pathway that facilitates MHCI expression and MHCI-dependent antigen presentation by microglia to CD8

Indexed as

AnimalsCell LineCells, CulturedDose-Response Relationship, DrugFemaleKv1.3 Potassium ChannelLipopolysaccharidesMacrophagesMiceMice, Inbred C57BLMicrogliaProteomicsKv1.3 Potassium ChannelLipopolysaccharidesKv1.3MicrogliaNeuroinflammationPotassium channelsProteomics

Identifiers

PMID28651603
PMCPMC5485721
OpenAlexW2712049910

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.